/Investor DB

O2h Ventures — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Five Alarm Biofivealarmbio.comFeb 2023

Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases.

BiotechLongevity

William Bains(Founding scientist)in

Co-investorsCambridge Angels groupSyndicateRoom

Penciltrypencil.comin𝕏Sep 2023Acquired

Pencil is an AI operating system for enterprise marketing teams that turns a campaign brief into finished images, video, and copy, automating generation, in-browser editing, multi-stakeholder review, publishing, and performance prediction.

AI & Machine LearningEnterprise SoftwareMarketing TechSingapore, SG

Will Hanschell(CEO)inSumukh Avadhani(CTO)in

Co-investorsBrandtech VenturesEntrepreneur FirstWavemaker PartnersArtesianCatapult VenturesMartlet Capital+6 more

PharmEnablepharmenable.cominMay 2023 · $7.5M

PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.

AI & Machine LearningBiotechDeep Tech

Hannah Sore(Founder)in

Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesParkwalk AdvisorsWren Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.